SMART-COP Score Calculator – Severe Community-Acquired Pneumonia Risk

Clinical calculation support · Verify results before clinical use

SMART-COP Assessment

Enter the patient's clinical findings at initial assessment. Select one oxygenation method appropriate to the patient's respiratory support.

—Points
S

Systolic blood pressure

Low systolic blood pressure is defined as SBP <90 mmHg.

2 points
M

Multilobar chest radiograph involvement

Infiltrates involving more than one lobe on chest radiography.

1 point
A

Albumin

Hypoalbuminaemia threshold: <3.5 g/dL (35 g/L).

1 point
If your laboratory reports g/L, divide by 10 before entry.
R

Respiratory rate

Age-adjusted threshold: ≥25/min at age ≤50 years; ≥30/min at age >50 years.

1 point
T

Tachycardia

Heart rate ≥125 beats/min.

1 point
C

Confusion

New-onset confusion or altered mental status.

1 point
O

Oxygenation

Choose the measurement appropriate to the patient's oxygen condition. The age-specific threshold is applied automatically.

2 points
P

Arterial pH

Acidaemia threshold: arterial pH <7.35.

2 points
—SMART-COP
Predicted need for intensive respiratory or vasopressor support
Complete all required fields
The score will be calculated when all required clinical data are entered.
Clinical interpretation

Enter the required clinical variables to calculate the SMART-COP score.

A score ≥3 identifies patients at increased risk of requiring intensive respiratory or vasopressor support (IRVS). This is a prediction aid, not a substitute for clinical assessment or an automatic ICU admission rule.

About the SMART-COP Score

SMART-COP is a clinical prediction tool developed to identify adults with community-acquired pneumonia (CAP) who may require intensive respiratory or vasopressor support (IRVS). It is not primarily a 30-day mortality score.

The eight components are systolic blood pressure, multilobar radiographic involvement, albumin, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH. The score ranges from 0 to 11 points.

Scoring criteria

ComponentCriterionPoints
Systolic blood pressure<90 mmHg2
Multilobar involvementMore than one lobe on chest radiograph1
Albumin<3.5 g/dL1
Respiratory rateAge ≤50: ≥25/min; age >50: ≥30/min1
Tachycardia≥125 beats/min1
ConfusionNew-onset confusion1
OxygenationAge ≤50: PaO₂ <70 mmHg or SpO₂ ≤93% on room air; if on oxygen, P/F <333. Age >50: PaO₂ <60 mmHg or SpO₂ ≤90% on room air; if on oxygen, P/F <250.2
Arterial pH<7.352

Score interpretation

ScoreRisk of needing IRVSApproximate frequency in original interpretation
0–2Low—
3–4Moderate1 in 8
5–6High1 in 3
≥7Very high2 in 3

A score ≥5 is commonly used to identify severe CAP. The original study's ≥3 threshold identified 92% of patients who received IRVS; this sensitivity figure is not an individual patient's probability of requiring support.

Clinical Use & Limitations

  • Designed for adult patients with community-acquired pneumonia assessed at initial presentation.
  • Use clinical findings and investigations from the same assessment episode.
  • Age modifies respiratory-rate and oxygenation thresholds; age itself does not contribute points.
  • The oxygenation criterion contributes 2 points if the selected applicable threshold is met; do not add points for multiple oxygenation measures.
  • SMART-COP predicts IRVS need; it does not independently determine diagnosis, mortality, or the appropriate care location.
  • Patients already requiring invasive ventilation or vasopressors need immediate critical-care management; do not delay escalation to calculate a score.

Guideline context

The 2025 ATS guideline update retains previously validated severe-CAP criteria for defining severity; it addresses lung ultrasound, respiratory-virus testing, antibiotic duration, and corticosteroids rather than endorsing SMART-COP as a mandatory disposition rule. The 2019 ATS/IDSA guideline recommends direct ICU admission for CAP with hypotension requiring vasopressors or respiratory failure requiring mechanical ventilation, and suggests the IDSA/ATS minor criteria plus clinical judgement for patients without these major criteria. SMART-COP remains an alternative validated prediction rule for IRVS risk, not a stand-alone ICU admission mandate.

References

Charles PG, Wolfe R, Whitby M, et al.SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clinical Infectious Diseases. 2008;47(3):375–384. DOI: 10.1086/589754.
Jones BE, Ramirez JA, Oren E, et al.Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2026;212(1):24–44. Published online 2025. DOI: 10.1164/rccm.202507-1692ST.
Metlay JP, Waterer GW, Long AC, et al.Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the ATS and IDSA. American Journal of Respiratory and Critical Care Medicine. 2019;200(7):e45–e67. DOI: 10.1164/rccm.201908-1581ST.
Memon RA, Rashid MA, Avva S, et al.The Use of the SMART-COP Score in Predicting Severity Outcomes Among Patients With Community-Acquired Pneumonia: A Meta-Analysis. Cureus. 2022;14(7):e27248. DOI: 10.7759/cureus.27248.
Severe Community-Acquired Pneumonia.Review summarizing SMART-COP components and oxygenation thresholds. PMCID: PMC7126707. Read article.
Clinical disclaimer: This calculator is intended for healthcare professionals as a clinical decision-support aid. It does not replace clinical judgement, local protocols, or assessment of the patient's overall condition. A low score does not exclude deterioration. Do not delay urgent respiratory or circulatory support while completing this assessment.